With the current rise in nanomaterials development and study, a concurrent increase in the studies on nanomaterials safety assessment is necessary. The POTENTIAL project, coordinated by the Istituto di Ricerche Farmacologiche Mario Negri IRCCS (IRFMN – Italy), has been build up to answer this prominent need
POTENTIAL (Platform Optimisation To Enable NanomaTerIAL safety assessment for rapid commercialisation) is a Horizon Europe project aiming at standardising how Nanomaterials are investigated. As reiterated by Dr. Luisa Diomede, POTENTIAL coordinator “We have several methods to quantify how nanomaterials can be hazardous. However, it is important that any methodology we may use is designed to be interoperable between laboratories, applicable in an industrial setting, and ultimately becomes standard”.
The Project aim at developing methodologies and protocols for the detection, quantification and characterisation of nanomaterials to ultimately obtain interchangeable protocols among laboratories across the world.
The generated results and knowledge will be of invaluable support for industries, governments, and consumers.
POTENTIAL consortium includes six research centres
the Royal College of Surgeons in Ireland (RCSI – Ireland); the Luxembourg Institute of Science and Technology (LIST – Luxembourg); the Centro de Investigation Cooperativa en Biomateriales (CICBiomagune – Spain); the Universitè Sorbonne Paris Nord (USP – France); the University of Leipzig (ULEI – Germany); and Zhejiang University (ZHE – China)
and five companies
The East European Research and Innovation Enterprise (EMERGE – Bulgaria); MyBiotech (Germany), Greendecision (Italy); Innova (Italy); and Graphenea (Spain).
The Project has received funding from the European Union’s Horizon Europe Research and Innovation Actions programme under Grant Agreement 101092901